LETTER
Palladium-Catalyzed Carbon–Sulfur Cross-Couplings
869
(7) Gogoi, P.; Gogoi, S. R.; Kalita, M.; Barman, P. Synlett 2013,
24, 873.
In conclusion, we have developed a highly efficient palla-
dium-catalyzed cross-coupling of arylsulfenyl chlorides
with arylboronic acids using a 2-[2-(benzylthio)phenyl-
iminomethyl]-4-bromophenol Schiff base palladium li-
gand as the catalyst. The ligands are readily prepared from
commercially available starting materials.
(8) Taniguchi, N. J. Org. Chem. 2007, 72, 1241.
(9) (a) Lindley, J. Tetrahedron 1984, 40, 1433. (b) Yamamoto,
T.; Sekine, Y. Can. J. Chem. 1984, 62, 1544. (c) Hickman,
R. J. S.; Christie, B. J.; Guy, R. W.; White, T. J. Aust. J.
Chem. 1985, 38, 899. (d) Van Bierbeek, A.; Gingras, M.
Tetrahedron Lett. 1998, 39, 6283.
(10) Herradura, P. S.; Pendola, K. A.; Guy, R. K. Org. Lett. 2000,
2, 2019.
Acknowledgment
(11) Han, M.; Lee, J. T.; Hahn, H.-G. Tetrahedron Lett. 2011, 52,
236.
(12) Xu, H.-J.; Zhao, Y.-Q.; Feng, T.; Feng, Y.-S. J. Org. Chem.
2012, 77, 2878.
The authors are grateful to Professor Franklin A. Davis, Department
of Chemistry, Temple University, Philadelphia, for valuable discus-
sions and suggestions, and Dr. Bipul Sarma, Department of Chemi-
cal Sciences, Tezpur University, India for assistance with X-ray
crystallography.
(13) (a) Kosugi, M.; Ogata, T.; Terada, M.; Sano, H.; Migita, T.
Bull. Chem. Soc. Jpn. 1985, 58, 3657. (b) Ciattini, P. G.;
Morera, E.; Ortar, G. A. Tetrahedron Lett. 1995, 36, 4133.
(c) Ishiyama, T.; Mori, M.; Suzuki, A.; Miyaura, N.
J. Organomet. Chem. 1996, 525, 225. (d) Mann, G.;
Baranano, D.; Hartwig, J. F.; Rheingold, A. L.; Guzei, I. A.
J. Am. Chem. Soc. 1998, 120, 9205. (e) Liebeskind, L. S.;
Srogl, J. Org. Lett. 2002, 4, 979. (f) Savarin, C.; Srogl, J.;
Liebeskind, L. S. Org. Lett. 2000, 2, 3229. (g) Aguilar, A.;
Liebeskind, L. S.; Pena-Cabrera, E. J. Org. Chem. 2007, 72,
8539. (h) Goriya, Y.; Ramana, C. V. Tetrahedron 2010, 66,
7642.
(14) (a) Evindar, G.; Batey, R. A. J. Org. Chem. 2006, 71, 1802.
(b) Chen, Y.-J.; Chen, H.-H. Org. Lett. 2006, 8, 5609.
(c) Zheng, Y.; Du, X.; Bao, W. Tetrahedron Lett. 2006, 47,
1217. (d) Sperotto, E.; van Klink, G. P. M.; de Vries, J. G.;
van Koten, G. J. Org. Chem. 2008, 73, 5625. (e) Xu, H.-J.;
Zhao, X.-Y.; Fu, Y.; Feng, Y.-S. Synlett 2008, 3063.
(f) Enguehard-Gueiffier, C.; Thery, I.; Gueiffier, A.;
Buchwald, S. L. Tetrahedron 2006, 62, 6042. (g) Bandgar,
B. P.; Bettigeri, S. V.; Phopase, J. Org. Lett. 2004, 6, 2105.
(15) (a) Cochran, J. C.; Friedman, S. R.; Frazier, J. P. J. Org.
Chem. 1996, 61, 1533. (b) Borisov, A. V.; Belsky, V. K.;
Goncharova, T. V.; Borisova, G. N.; Osmanov, V. K.;
Matsulevich, Zh. V.; Frolova, N. G.; Savin, E. D. Chem.
Heterocycl. Compd. 2005, 41, 771.
References and Notes
(1) (a) Liu, L.; Stelmach, J. E.; Natarajan, S. R.; Chen, M.-H.;
Singh, S. B.; Schwartz, C. D.; Fitzgerald, C. E.; O’Keefe, S.
J.; Zaller, D. M.; Schmatz, D. M.; Doherty, J. B. Bioorg.
Med. Chem. Lett. 2003, 13, 3979. (b) Kaldor, S. W.; Kalish,
V. J.; Davies, J. F.; Shetty, B. V.; Fritz, J. E.; Appelt, K.;
Burgess, J. A.; Campanale, K. M.; Chirgadze, N. Y.;
Clawson, D. K.; Dressman, B. A.; Hatch, S. D.; Khalil, D.
A.; Kosa, M. B.; Lubbehusen, P. P.; Muesing, M. A.; Patick,
A. K.; Reich, S. H.; Su, K. S.; Tatlock, J. H. J. Med. Chem.
1997, 40, 3979.
(2) Davis, F. A. J. Org. Chem. 2006, 71, 8993.
(3) (a) Williams, T. M.; Ciccarone, T. M.; MacTough, S. C.;
Rooney, C. S.; Balani, S. K.; Condra, J. H.; Emini, E. A.;
Goldman, M. E.; Greenlee, W. J.; Kauffman, L. R.; O’Brien,
J. A.; Sardana, V. V.; Schleif, W. A.; Theoharides, A. D.;
Anderson, P. S. J. Med. Chem. 1993, 36, 1291. (b) Silvestri,
R.; De Martino, G.; La Regina, G.; Artico, M.; Massa, S.;
Vargiu, L.; Mura, M.; Loi, A. G.; Marceddu, T.; La Colla, P.
J. Med. Chem. 2003, 46, 2482.
(4) (a) Avis, I.; Martínez, A.; Tauler, J.; Zudaire, E.; Mayburd,
A.; Abu-Ghazaleh, R.; Ondrey, F.; Mulshine, J. L. Cancer
Res. 2005, 65, 4181. (b) De Martino, G.; La Regina, G.;
Coluccia, A.; Edler, M. C.; Barbera, M. C.; Brancale, A.;
Wilcox, E.; Hamel, E.; Artico, M.; Silvestri, R. J. Med.
Chem. 2004, 47, 6120. (c) Funk, C. D. Nat. Rev. Drug
Discovery 2005, 4, 664. (d) Khandekar, S. S.; Gentry, D. R.;
Van Aller, G. S.; Doyle, M. L.; Chambers, P. A.;
(16) Ligands HL1 and HL2
The ligands, 2-[2-(benzylthio)phenyliminomethyl]-4-
bromophenol (HL1) and N-[2-(benzylthio)phenyl]salicyl-
aldimine (HL2) were synthesized according to the literature
method, see ref. 17.
[PdL1Cl] (1a)
Konstantinidis, A. K.; Brandt, M.; Daines, R. A.; Lonsdale,
J. T. J. Biol. Chem. 2001, 276, 30024.
2-[2-(Benzylthio)phenyliminomethyl]-4-bromophenol
(HL1) (199 mg, 0.50 mmol) was dissolved in EtOH (10 mL)
and a solution of sodium tetrachloropalladate (153 mg, 0.52
mmol) in EtOH (10 mL) was added dropwise. The mixture
was stirred in a water-bath at 90 °C for 0.5 h during which
the color of the solution changed to bright orange–yellow.
The solution was then allowed to stand for 2 h, which
resulted in the formation of orange–red needle-like crystals
suitable for X-ray diffraction. These were filtered, washed
with 25% EtOH–H2O and dried under vacuum (10–2 Torr).
The purity was assessed by TLC.
(5) (a) Itoh, T.; Mase, T. Org. Lett. 2004, 6, 4587. (b) Bates, C.
G.; Gujadhur, R. K.; Venkataraman, D. Org. Lett. 2002, 4,
2803. (c) Kreis, M.; Brase, S. Adv. Synth. Catal. 2005, 347,
313. (d) Migita, T.; Shimizu, T.; Asami, Y.; Shiobara, J.;
Kato, Y.; Kosugi, M. Bull. Chem. Soc. Jpn. 1980, 53, 1385.
(e) Fernandez-Rodriguez, M. A.; Shen, Q. L.; Hartwig, J. F.
J. Am. Chem. Soc. 2006, 128, 2180. (f) Alvaro, E.; Hartwig,
J. F. J. Am. Chem. Soc. 2009, 131, 7858. (g) Jiang, Z.; She,
J.; Lin, X. F. Adv. Synth. Catal. 2009, 351, 2558. (h) Bhadra,
S.; Sreedhar, B.; Ranu, B. C. Adv. Synth. Catal. 2009, 351,
2369. (i) Rout, L.; Sen, T. K.; Punniyamurthy, T. Angew.
Chem. Int. Ed. 2007, 46, 5583. (j) Correa, A.; Carril, M.;
Bolm, C. Angew. Chem. Int. Ed. 2008, 47, 2880. (k) Reddy,
V. P.; Kumar, A. V.; Swapna, K.; Rao, K. R. Org. Lett. 2009,
11, 1697. (l) Ku, X.; Huang, H.; Jiang, H.; Liu, H. J. Comb.
Chem. 2009, 11, 338.
Yield: 322 mg (86%); orange-red needles; mp 250 °C. IR
(KBr): 1620 (s), 1439 (s), 752 (s), 560 (s) cm–1. Anal. Calcd
for C20H15ONSPdBrCl: C, 44.55; H, 2.80; N, 2.60; S, 5.95.
Found: C, 44.75; H, 2.90; N, 2.57; S, 5.85.
[PdL2Cl] (1b)
Complex 1b was prepared from N-[2-(benzylthio)phenyl]-
salicylaldimine (HL2) using the same procedure as that
described for 1a.
(6) Bahekar, S. S.; Sarkate, A. P.; Wadhai, V. M.; Wakte, P. S.;
Shinde, D. B. Catal. Commun. 2013, 41, 123.
Yield: 274 mg (80%); orange–red crystals; mp 256 °C. IR
© Georg Thieme Verlag Stuttgart · New York
Synlett 2014, 25, 866–870